Media Summary: In this video, Kathryn Tringale, MD, Memorial Sloan Kettering Cancer Center, New York City, NY, discusses a study which ... James L. Rubenstein, University of California, San Francisco, US, provides the James Rubenstein, MD, PhD, University of California San Francisco, San Francisco, CA, shares the findings of a study in which ...

Evaluating Longitudinal Consolidation Patterns In Patients With Primary Cns Lymphoma - Detailed Analysis & Overview

In this video, Kathryn Tringale, MD, Memorial Sloan Kettering Cancer Center, New York City, NY, discusses a study which ... James L. Rubenstein, University of California, San Francisco, US, provides the James Rubenstein, MD, PhD, University of California San Francisco, San Francisco, CA, shares the findings of a study in which ... Mark Roschewski, MD, National Cancer Institute, Bethesda, MD, briefly discusses a study Matthew Frigault, MD, Harvard Medical School, Boston, MA, presents findings from a phase I/II trial (NCT02445248) Lakshmi Nayak, MD, Dana-Farber Cancer Institute, Boston, MA, shares insights into the neurological symptoms associated with ...

Lakshmi Nayak, MD, Dana-Farber Cancer Institute, Boston, MA, comments on the Phase II PROSPECT trial (NCT04947319), ... Kathryn Tringale, MD, UC San Diego Health, San Diego, CA, discusses the treatment paradigm for Visit our website for more information www.pasno.org Neuro-Oncology Webinar Series (NOWS) About NOWS: Pakistan Society of ... Gareth Gregory, MBBS, PhD, FRACP, FRCPA, Monash University, Monash Health, Melbourne, Australia, discusses challenges in ...

Photo Gallery

Evaluating longitudinal consolidation patterns in patients with primary CNS lymphoma
Consolidation strategies for CNS lymphoma
Analyzing patterns of disease failure in patients with primary CNS lymphoma
Identification of genomic biomarkers of disease progression & survival in primary CNS lymphoma
TEDDi-R regimen for secondary CNS lymphoma
Tisa-cel in patients with primary CNS lymphoma
Neurological symptoms indicative of primary CNS lymphoma: advice for community physicians
The Phase II PROSPECT trial: the efficacy and safety of tirabrutinib in R/R primary CNS lymphoma
Updates in Primary Central Nervous System Lymphoma (PCNSL)
Comparing consolidation options in CNS lymphoma: autoSCT & reduced-dose whole-brain radiation
Neurosurgical Evaluation and Treatment of Lymphoma by Dr. Chad W. Washington
Insights into the diagnosis of primary CNS lymphoma and challenges in this space
Sponsored
View Detailed Profile
Evaluating longitudinal consolidation patterns in patients with primary CNS lymphoma

Evaluating longitudinal consolidation patterns in patients with primary CNS lymphoma

In this video, Kathryn Tringale, MD, Memorial Sloan Kettering Cancer Center, New York City, NY, discusses a study which ...

Consolidation strategies for CNS lymphoma

Consolidation strategies for CNS lymphoma

James L. Rubenstein, University of California, San Francisco, US, provides the

Analyzing patterns of disease failure in patients with primary CNS lymphoma

Analyzing patterns of disease failure in patients with primary CNS lymphoma

... which analyzed

Identification of genomic biomarkers of disease progression & survival in primary CNS lymphoma

Identification of genomic biomarkers of disease progression & survival in primary CNS lymphoma

James Rubenstein, MD, PhD, University of California San Francisco, San Francisco, CA, shares the findings of a study in which ...

TEDDi-R regimen for secondary CNS lymphoma

TEDDi-R regimen for secondary CNS lymphoma

Mark Roschewski, MD, National Cancer Institute, Bethesda, MD, briefly discusses a study

Sponsored
Tisa-cel in patients with primary CNS lymphoma

Tisa-cel in patients with primary CNS lymphoma

Matthew Frigault, MD, Harvard Medical School, Boston, MA, presents findings from a phase I/II trial (NCT02445248)

Neurological symptoms indicative of primary CNS lymphoma: advice for community physicians

Neurological symptoms indicative of primary CNS lymphoma: advice for community physicians

Lakshmi Nayak, MD, Dana-Farber Cancer Institute, Boston, MA, shares insights into the neurological symptoms associated with ...

The Phase II PROSPECT trial: the efficacy and safety of tirabrutinib in R/R primary CNS lymphoma

The Phase II PROSPECT trial: the efficacy and safety of tirabrutinib in R/R primary CNS lymphoma

Lakshmi Nayak, MD, Dana-Farber Cancer Institute, Boston, MA, comments on the Phase II PROSPECT trial (NCT04947319), ...

Updates in Primary Central Nervous System Lymphoma (PCNSL)

Updates in Primary Central Nervous System Lymphoma (PCNSL)

Lymphoma

Comparing consolidation options in CNS lymphoma: autoSCT & reduced-dose whole-brain radiation

Comparing consolidation options in CNS lymphoma: autoSCT & reduced-dose whole-brain radiation

Kathryn Tringale, MD, UC San Diego Health, San Diego, CA, discusses the treatment paradigm for

Neurosurgical Evaluation and Treatment of Lymphoma by Dr. Chad W. Washington

Neurosurgical Evaluation and Treatment of Lymphoma by Dr. Chad W. Washington

Visit our website for more information www.pasno.org Neuro-Oncology Webinar Series (NOWS) About NOWS: Pakistan Society of ...

Insights into the diagnosis of primary CNS lymphoma and challenges in this space

Insights into the diagnosis of primary CNS lymphoma and challenges in this space

Gareth Gregory, MBBS, PhD, FRACP, FRCPA, Monash University, Monash Health, Melbourne, Australia, discusses challenges in ...

Primary Central Nervous System Lymphoma

Primary Central Nervous System Lymphoma

The